Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
Eun Mi SongDong-Hoon YangSun Mi LeeHyun Ju YooSu Jung KimSun-Ho LeeKiju ChangSung Wook HwangDong-Hoon YangJin-Yong JeongPublished in: Digestive diseases and sciences (2018)
There were changes in the profiles of fecal fatty acid metabolomes in CRC patients compared to healthy controls, implying that fecal fatty acids could be used as a novel screening tool for CRC.